Lotus Eye Hospital and Institute profitability ratios
Per cent unless marked ×
| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
Returns | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |||||
|---|---|---|---|---|---|---|
| 0.1% | 0.1% | 1.2% | 5.0% | 7.1% | ||
| 0.1% | 0.1% | 1.1% | 4.5% | 6.5% | ||
| −0.5% | −0.5% | 0.7% | 4.7% | 7.9% | ||
| 0.3% | −0.2% | 0.4% | 3.6% | 6.2% | ||
Margins | ||||||
| 8.5% | 6.3% | 6.9% | 13.6% | 16.1% | ||
| −0.7% | −0.7% | 0.9% | 5.8% | 9.8% | ||
| — | −19.1% | −175.7% | −154.7% | — | ||
| 0.4% | −0.1% | 2.8% | 8.3% | 12.0% | ||
| 0.3% | 0.2% | 1.5% | 6.1% | 8.7% | ||
| −18.4% | −18.4% | 0.2% | 0.1% | 2.7% | ||
Additional | ||||||
| 34.2% | 250.0% | 46.5% | 27.4% | 27.9% | ||
| — | 14.6% | 1.4% | 35.7% | 25.5% | ||
| 0.1% | 0.1% | 1.2% | 3.2% | 5.3% | ||
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.